Background {#Sec1}
==========

In developing countries including Ethiopia, life expectancy is increasing. This is partly as a result of increased healthcare seeking behavior in the society and increased access to health service \[[@CR1], [@CR2]\]. Related to this, population aging has resulted in an increased prevalence of chronic diseases and thus rise in hospitalizations and healthcare costs of older adults \[[@CR3]\].

The geriatric population is at high risk of drug related problems (DRPs) due to the age-related pharmacokinetic and pharmacodynamic changes \[[@CR4]\]. Furthermore, a higher incidence of drug related problems could result from age associated increased prevalence of multiple chronic diseases, which causes the use of complex therapeutic regimens \[[@CR5]\]. According to pharmaceutical care network of Europe (PCNE), *DRP is defined as, "an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes"* \[[@CR6]\]*.* DRPs are associated with increased healthcare costs and hospital admissions, prolonged hospital stays, reduced quality of life, and increased mortality \[[@CR7], [@CR8]\]. Therefore, drug prescribing and use in older patients needs special considerations including avoidance of inappropriate drugs, rational utilization of indicated medications, side effects monitoring, prevention of drug-drug interactions, and evaluation of adherence and patient involvements \[[@CR9]\].

The identification, resolution, and prevention of DRPs have been described as a core process of pharmaceutical care. Clinical pharmacists are suitably trained to carry out medication reviews in geriatric patients and have been found to improve the use of high-risk medications and improve the accuracy of medication regimens \[[@CR10], [@CR11]\]. In order to resolve DRPs, the cause should be identified and DRPs should be classified appropriately. For such purpose, the classification of DRPs is crucial. There are several classifications for DRPs. However, there is no single standardized classification in the world \[[@CR12]\]. The PCNE classification system is commonly practiced and has better usability and internal consistency as it is updated and revised periodically. It is very important for the documentation of DRPs in the pharmaceutical care process \[[@CR13]\].

Ethiopia is the second from the top six countries, in which life expectancy and the number of geriatric population is increasing \[[@CR14]\] however, there is limited attention for these older patients. Most of the health sciences training programs didn't include gerontology training in their curriculums and there is no guideline that focuses on geriatric medicine. At the hospital level, geriatric wards are not established for these special populations.

As with other health care services, geriatrics care requires health care professional team work including clinical pharmacists. Experience from developed nations has shown involving clinical pharmacist in patient care resulted in a reduction of DRPs as well as associated costs \[[@CR15], [@CR16]\]. Despite the good start up including patient-oriented pharmacy curriculum, clinical pharmacy service is still at the infant stage in Ethiopia. With poor involvement of clinical pharmacists on geriatric care, there is limited information on magnitude of DRPs, determinant factors and clinical pharmacist's interventions among geriatric patients in hospital set up. Therefore, this study aimed to identify drug related problems and determinants in geriatric patients admitted to medical and surgical wards, and to evaluate the impact of clinical pharmacist interventions for treatment optimization.

Methods {#Sec2}
=======

Study design and setting {#Sec3}
------------------------

A prospective interventional study was conducted at medical and surgical wards of Jimma University medical center (JUMC). JUMC is the only teaching and referral hospital with 500 beds in the southwestern part of the country located in Jimma town, Southwest Ethiopia, 352 km far from Addis Ababa.

Study population {#Sec4}
----------------

All geriatric patients ≥60 years who were admitted for at least 24 h in the medical and surgical wards of JUMC during the study period (01 April 2017 to 31 July 2017) were included. Geriatrics patients were defined as patients age 60 years and older. Although most developed world countries have accepted the chronological age of 65 years as a definition of 'elderly', this does not adapt well to the situation in Africa and it can be extended to 60 years and above \[[@CR17], [@CR18]\]. Accordingly, we used the cut point of 60 years old in our study. Geriatric patients re-admitted during the study period and patients who refused to participate in the study were excluded.

Data collection {#Sec5}
---------------

Patients were interviewed using a standard questionnaire and their respective medical chart was reviewed using data abstraction format. Four MSc clinical pharmacists were involved in the identification, interventions and, documentation of DRPs. DRPs were identified by using the following literature resources such as Ethiopian guidelines, European or American standard guidelines such as, American diabetic association for diabetes, American heart associationguideline for heart failure, American urologic association guideline for benign prostatic hyperplasia, world health organization guideline for surgical site infection prophylaxis and other relevant guidelines for the respective diseases identified. Moreover, adverse drug reactions (ADR) were assessed according to the NaranjoADR probability scale \[[@CR19]\]. Micromedex was used to check drug-drug interactions. Pharmaceutical care network Europe (PCNE) DRPs classification system was used to classify and document DRPs \[[@CR6]\]. For the identified DRPs, intervention was provided through discussion with individual prescriber immediately. Additionally, recommendations were forwarded during rounds and morning sessions orally and/or with written documents and the prescriber acceptance documented. DRPs which are not accepted were further discussed with a senior physician for confirmation. The acceptance of the recommended interventions was followed to check for their implementations and the status of the intervention was documented.

Outcome measure {#Sec6}
---------------

We have two main objectives in the study. The first objective is to measure the prevalence and determinates of DRPs among geriatric population attending surgical and internal medicine wards of JUMC. The second objective of the study is measuring the impact of clinical pharmacy intervention on reducing the number of DRPs and the acceptance rate of clinical pharmacists' intervention by prescribers.

Explanatory variables {#Sec7}
---------------------

DRPs were identified by evaluating the appropriateness of drug therapy in terms of indication, dosage, safety, and efficacy. For the identified DRPs, the clinical pharmacists provided interventions. Clinical pharmacist interventions were defined as any action by a clinical pharmacist that directly results in a change of patient management. The Pharmaceutical care network Europe DRPs classification system \[[@CR6]\] used in this study have different parts that include: i) The problems(e.g. effect of drug treatment not optimal, unnecessary drug-treatment), ii) causes (e.g., drug dose too low, wrong drug administered, inappropriate timing or dosing intervals), iii) planned interventions (e.g. intervention discussed with prescriber, patient (drug) counselling), iv) acceptance of the intervention proposals (intervention accepted or not accepted) and v) outcome of the intervention (problem solved, partially solved or unsolved). Different interventions were applied for some of the DRPs that resulted in the number of interventions greater than the number of DRPs.

The other variables assessed were (1) socio-demographics (including sex, age, financial status, educational level, residence, marital status, and social support) (2) disease related factors (diagnosis, co-morbidities) and (3) drug/therapy related factorsthat include **(**polypharmacy, class and type of drugs).Poly-pharmacy was considered when the patients were prescribed with five or more drugs together. Patients who had one or more additional disease condition in addition to the main disease were considered as having comorbidity.

Statistical analyses {#Sec8}
--------------------

EpiData version 4.0.2. for data entry and Statistical Package for Social Science (SPSS) version 20 (IBM SPSS version 20.0 Inc., Chicago, Illinois) were used for data analysis. Categorical variables were expressed in terms of frequencies and percentages. Continuous variables were presented using mean and standard deviation. The proportion of DRPs and prescriber's acceptance rate of the intervention were reported using these descriptive statistics. Univariable logistic regression analysis and multivariable logistic regression analysis was performed to determine the potential determinant of DRPs. Results were reported as odds ratios (ORs) with 95% CIs. A *p* value of less than 0.05 was considered significant.

Results {#Sec9}
=======

Socio-demographic characteristics {#Sec10}
---------------------------------

A total of 200 patients were included in the final analysis. Of this, 135(67.5%) were male, the mean (SD) age was 67.3 (7.5) years, and the majority (68.5%) of the patients were from rural areas. Two third of the patients did not have a formal education and only 36.5% of the patients had a monthly income of ≥800 Ethiopian Birr. Furthermore, 75% of them relied on the caregiver (Table [1](#Tab1){ref-type="table"}). Table 1The Socio-Demographic Characteristics of geriatric patients admitted from April to July to Medical and Surgical wards of JUMC, Ethiopia, 2017 (*N* = 200)Demographic characteristicsN (%)Age, Mean (SD)67.3 (7.3)Sex male135 (67.5)Marital status Married158 (79) Widowed36 (18) Divorced6 (3)Religion Christian50 (25) Muslim150 (75)Educational status No formal education132 (66) Primary education55 (27.5) Secondary education8 (4) Tertiary education5 (2.5)Residence Rural137 (68.5) Urban63 (31.5)Monthly income  \< 800 birr127 (63.5)  ≥ 800 birr73 (36.5)Relies on caregiver (yes)150 (75%)

Clinical and medication characteristics {#Sec11}
---------------------------------------

The majority (65. 5%) of the patients were admitted to the medical ward. Participants had an average of 2.20 (SD1.57) clinical conditions and they took an average of 3.90 (SD2.11). The most common medical condition was heart failure (24%) followed by stroke (13%) and benign prostatic hyperplasia (11%). Polypharmacy was present in 35.5% of the patients (Table [2](#Tab2){ref-type="table"}). Table 2Clinical, and medication related characteristics in geriatric patients admitted from April to July at Medical and Surgical wards of JUMC, Ethiopia, 2017 (*N* = 200)Characteristicsn (%)Admission ward Medical131 (65.5) Surgical69 (34.5) Mean number of disease condition per patient, Mean (SD)2.20 (1.157) Mean number of medications per patient, Mean (SD)3.9 (2.108) Polypharmacy (yes)71 (35.5)Disease conditions Heart failure48 (24) BPH26 (13) Stroke22 (11) Acute coronary syndrome13 (6.5) Acute abdomen12 (6) Type II DM11 (5.5) Cancer9 (4.5) Pneumonia8 (4) Surgical site infection8 (4) Chronic kidney disease7 (3.5) Trauma6 (3) Hernia5 (2.5) Hematoma5 (2.5) Gangrene5 (2.5) Upper GI bleeding5 (2.5) Others10 (5)

Prevalence of drug related problems {#Sec12}
-----------------------------------

A total of 380 DRPs were identified from 81.5% of the study participants. Every patient had an average of 1.90 (SD1.47) DRPs. The most commonly found DRPs belonged to the treatment effectiveness related (effect of drug treatment not optimal, untreated indication, and no effect of drug treatment) with 47.6%, followed by (unnecessary drug treatment, problem with the cost-effectiveness of treatment) 28.2%, and adverse drug event 24.2%. Regarding the number of DRPs, 24.5% had one, 26.5% of patients had two, and 30.5% had three and more DRPs (Table [3](#Tab3){ref-type="table"}). Some examples and description of DRPs were provided in Table [4](#Tab4){ref-type="table"}. Table 3DRP categories and number of DRPs among geriatric patients admitted from April to July to Medical and Surgical wards of JUMC, Ethiopia, 2017Total number of DRPs =380n (%)Problem domains P1: treatment effectiveness (3 categories)181 (47.6%) Suboptimal effect of drug treatment102 (56.4) Untreated indication69 (38.1) No effect of drug treatment10 (5.5) P2: treatment safety92 (24.2%) Adverse drug event (possibly) occurred92 (100) P3: Others107 (28.2%) Unnecessary drug treatment81 (75.7) Problem with cost effective treatment26 (24.3)Number of drug related problemsFrequency (%) None37 (18.5) One49 (24.5) Two53 (26.5)  ≥ three61 (30.5) Table 4Some examples of DRPs among geriatric patients admitted from April to July to Medical and Surgical wards of JUMC, Ethiopia, 2017Drug related problemCategory of DRPsDescriptionA patient in the age range of 60--70 was admitted to surgical ward with the diagnosis of breast cancer. After one side mastectomy was done, the patient was prescribed with Tamoxifen 20 mg po daily.Untreated indicationPatient complained severe pain which is 8/10. However, the pain was not treated. Patient has untreated indication and needs morphine 2.5 mg every four hour.A patient in the age range of 60--70 was admitted to internal medicine ward with the diagnosis of ischemic heart disease (NST Elevated myocardial infarction). The patient was prescribed with Simvastatin 40 mgSuboptimal effect of drug treatmentHigh intensity statins are required for patients with NSTEMI. Simvastatin 40 mg is medium intensity statin. Thus, it will have suboptimal effect. Therefore, we recommended Atorvasatin 80 mg.A patient in the age range of 70--80 admitted with the diagnosis of peripheral arterial disease. After admission the patient prescribed with warfarin 5 mg and Heparin 12,500 IUNo effect of drug treatment (Warfarin and Heparin)Untreated indicationWarfarin and Heparin have no effect on peripheral arterial.Patient needs Atorvastatin and Aspirin to treat his condition.Known cardiac patient in the age of 80--90 was admitted to internal medicine ward. The patient was taking aspirin and lost around 3 l of blood.Adverse drug event (possibly) occurredAspirin was considered the offensive drug and discontinued for 07 days. The bleeding stopped after aspirin was discontinued. Based on Naranjo scale the bleeding is possibly due to Aspirin.

Causes of drug related problems {#Sec13}
-------------------------------

Four hundred sixty six causes of DRPs were identified. Of this, the most common causes of DRPs were inappropriate drug selection (54.1%) followed by inappropriate dose selection (14.6%) and drug use process (12.2%). Among the inappropriate drug selection causes, the presence of new indication for drug treatment (36.1%) was the most common cause followed by no indication for the prescribed drug (20.6%), and inappropriate drug according to guidelines (16.7%) (Table [5](#Tab5){ref-type="table"}). The most frequently involved class of drugs in DRPs were cardiovascular agents (38.1%) followed by antibiotics (21%), and hematological agents (19.7%) (Fig. [1](#Fig1){ref-type="fig"}). Table 5Causes of DRPs identified in geriatric patients admitted from April to July to Medical and Surgical wards of JUMC, Ethiopia, 2017Cause domain (8 categories) total = 466n (%)C1: Drug selection causes252 (54.1)New indication for drug treatment91 (36.1)No indication for drug52 (20.6)Inappropriate drug according to guidelines42 (16.7)Contra-indicated30 (11.9)Inappropriate duplication of therapeutic20 (7.9)Inappropriate combination of drugs, or drugs and food17 (6.8)C2: Drug form causes16 (3.4)In appropriate drug form16 (100)C3: dose selection causes68 (14.6)Drug dose too high46 (67.6)Drug dose too low22 (32.4)C4: treatment duration causes24 (5.2)Duration of treatment too long22 (91.7)Duration of treatment too short2 (8.3)C5: dispensing causes20 (4.3)Prescribed drug not available18 (90)Prescribing error (necessary information missing)2 (10)C6: drug use process causes57 (12.2)Drug not administered at all40 (70.2)Drug under administered11 (19.3)Drug over administered at all6 (10.5)C7: patient related causes22 (4.7)Patient uses unnecessary drug7 (31.8)Patient administered/uses drug in a wrong way5 (22.7)Patient cannot afford drug5 (22.7)Patient unable to use drug/form as directed5 (22.7)C8: other causes7 (1.5)No or inappropriate outcome monitoring7 (100) Fig. 1Class of drugs involved in drug related problems in geriatric patients admitted from April to July to medical and surgical wards of JUMC, Ethiopia, 2017

Clinical pharmacist interventions {#Sec14}
---------------------------------

For identified DRPs, a total of 670 interventions were provided at different levels. Most of the interventions (41%) were provided at the prescriber level, followed by 39.1% at drug level, and 16.1% at patient/caregiver level. At the prescriber level, interventions proposed and discussed with the prescriber were the commonest (82.7%) form of intervention. Out of the interventions carried out at the drug level, the drug stopped and a new drug started was the most common with 30.5% each of them. The prescriber's acceptance rate was calculated considering the interventions provided at the prescriber level. Accordingly, out of 300 interventions performed at the prescriber level, 275(91.7%) of them were accepted. After the implementation of the interventions, out of the total DRPs, 65.8% of the problems were solved while 27.6% of the problems were not solved (Table [6](#Tab6){ref-type="table"}). Table 6Intervention, prescriber acceptance rate, and outcome of intervention for DRPs among geriatric patients admitted from April to July to Medical and Surgical wards of JUMC, Ethiopia, 2017Intervention domain (*N* = 731)n (%) I0: No intervention61 (8.3) I1: intervention at prescriber level300 (41.0) Intervention proposed and discussed with prescriber248 (82.7) Prescriber informed only52 (17.3) I2: intervention at patient /care giver level108 (16.1) Patient drug counseling84 (77.8) Spoken to family /care giver24 (22.2) I3: intervention at drug level262 (39.1) Drug stopped80 (30.5) New drug started80 (30.5) Dosage changed40 (15.3) Drug changed33 (12.6) Instruction for use changed17 (6.5) Formulation changed12 (4.6) I4: other intervention or activity0Intervention acceptance domain (*N* = 300) A1: intervention accepted at prescriber level275 (91.7) Intervention accepted and fully implemented249 (90.5) Intervention accepted but not implemented23 (8.4) Intervention accepted, implementation unknown0 Intervention accepted and partially implemented3 (0.1) A2: intervention not accepted25 (8.3) Intervention not accepted; no agreement24 (96) Intervention not accepted not feasible1 (4) A3: other (no intervention on acceptance)0Problem status domain (*N* = 380) O0: problem status unknown5 (1.3) O1: problem totally solved250 (65.8) O2: problem partially solved20 (5.3) O3: problem not solved105 (27.6) Lack of coordination of prescriber56 (53.3) No possibility to solve problem47 (44.8) Lack of coordination of patient2 (1.9)

Determinants of drug related problems {#Sec15}
-------------------------------------

In the multivariable logistic regression model, number of disease condition (AOR = 1.588, 95%CI = 1.029--2.450) and polypharmacy (AOR = 3.350, 95% CI = 1.212--9.260) have statically significant association with DRPs. Patients who took five or more medications (polypharmacy) are 3.350 times more likely to have DRPs than those who took less than five medications. Moreover, as clinical condition increases by one unit the likelihood of developing DRPs increases by 58.8% (Table [7](#Tab7){ref-type="table"}). Table 7Determinants of DRPs among geriatric patients admitted from April to July to medical and surgical wards of JUMC, Ethiopia, 2017Univariable logistic regression analysisMultivariate logistic regression analysisDeterminantsYes, n (%)No, n (%)*P* valueCOR (95% C.I)*P* valueAOR (95% C.I)Sex Male108 (66.3)27 (73 s)ReferenceReference Female55 (33.7)10 (27)0.431.37 (0.62--3.04)0.331.6 (0.62--4.12)Marital status Married128 (78.5)30 (81.1)ReferenceReference Divorced4 (2.5)2 (5.4)0.390.47 (0.08--2.68)0.721.2 (0.4--3.9) Widowed31 (19)5 (13.5)0.481.45 (0.52--4.04)0.125.7 (0.6--52)Educational level Educated56 (34.4)12 (32.4)ReferenceReference No formal education107 (65.6)25 (67.6)0.821.09 (0.51--2.33)0.421.2 (0.4--3.2)Reliance on care giver No39 (23.9)11 (29.7)ReferenceReference Yes124 (76.1)26 (70.3)0.4631.35 (0.61--2.96)0.551.3 (0.5--3.5)Economic status  ≥ 800 Birr61 (37.4)12 (32.4)ReferenceReference  \< 800 Birr102 (62.6)25 (67.6)0.570.80 (0.38--1.71)0.481.4 (0.5--3.6)Residence Urban52 (31.9)11 (29.7)ReferenceReference Rural111 (68.1)26 (70.3)0.790.903 (0.415--1.966)0.470.7 (0.3--1.8)Polypharmacy No97 (59.5)32 (86.5)ReferenceReference Yes66 (40.5)5 (13.5)0.0044.36 (1.61--11.75)0.023.35 (1.21--9.26) Comorbidities, mean (SD)2.20 (1.157)0.0061.79 (1.18--2.71)0.041.588 (1.03--2.45)*COR* Crude odds ratio, *AOR* Adjusted odds ratio, *CI* Confidence Interval

Discussion {#Sec16}
==========

Drug related problems are becoming a major public health concern. Geriatric patients are particularly highly vulnerable to DRPs caused by multiple factors such as polypharmacy and inappropriate prescribing \[[@CR20]\]. Identification and prevention of DRPs occurrence in this population is crucial. In our study, DRPs were present in 81.5% of the geriatric patients. This is in line with a study conducted by Ramanath K et al. in internal medicine rural tertiary care hospital of India, which showed an 83.4% prevalence of DRPs \[[@CR21]\].

Our study identified an average of 1.90 ± 1.47 DRPs per participant. This is somewhat lower than a study conducted by Chan et al. in Thailand, which showed an average of 2.2 ± 1.6 DRPs per participant \[[@CR22]\]. This can be explained by the setting difference. Our study was conducted in hospitalized patients where frequents patients visit by senior physicians and residents were applicable whereas the study in Thailand was conducted on outpatients where patients were less likely to meet senior physicians frequently. More than half (54.1%) of the DRPs resulted from inappropriate drug selection. Among the causes of inappropriate drug selection, having a new indication for drug treatment accounted for a higher proportion (36.1%). This is in line with an interventional study done in Belgium in geriatric wards, which reported the most frequent DRPs was an underuse of medications \[[@CR23]\].

After the identification and characterization of DRPs, interventions were proposed by the clinical pharmacists. Interventions were provided at prescriber level, at patient /caregiver level, and at drug level. The physician's acceptance rate of the clinical pharmacist's recommendations was determined based on the intervention acceptance rate at the prescriber level. Accordingly, the prescriber acceptance rate was high (91.7%). This is in line with a study conducted in Belgium (87.8%) \[[@CR23]\]. This finding has important implications for participating clinical pharmacists as part of the multidisciplinary team, can facilitate the identification of DRPs among geriatric patients and inform physicians to resolve the problems.

Another purpose of our study was to identify the determinants of DRPS. We found that patients with polypharmacy were more likely to develop DRPs than without polypharmacy. In accordance with the present results, previous studies \[[@CR23], [@CR24]\] have demonstrated that polypharmacy was a major determinant for the occurrence of DRPs. The observed association of polypharmacy with DRPs in geriatric patients could be as a result of increased health-care costs for the multiple medications, drug-interactions, disability/cognitive impairment, noncompliance to medications, increased risk of adverse drug events, falls and fractures, malnutrition, and functional status decline \[[@CR3], [@CR25]\]. We also found that patients having one or more co-morbidities had more DRPs. This finding is in agreement with Tegegneet al \[[@CR26]\], the finding which showed patients with comorbidities were at high risk of DRPS.

After the implementation of the clinical pharmacists' interventions, the status of DRPs was determined. The interventions solved around two-third (65.8%) of the existed drug related problems. However, around 27.6% of the DRPs remained unsolved as a result of lack of coordination of prescribers, no possibility to solve the DRPs and lack of coordination of the patients. These results are consistent with those of other studies which were able to solve 58.9--68.3% of identified drug related problems \[[@CR23]\].

Conclusion {#Sec17}
==========

Drug related problems were substantially high among geriatric inpatients. Patients with polypharmacy and co-morbidities had a much higher chance of developing DRPs. Hence, special attention is needed to prevent the occurrence of DRPs in these patients. Moreover, clinical pharmacists' intervention was found to reduce DRPs in geriatric inpatients. The prescriber acceptance rate of clinical pharmacists' intervention was also substantially high.
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